A Research Review of the Current Treatments for Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Purpose/Objectives: To review the research studies on the current treatments for radiation therapy- (RT-) induced mucositis in patients with head and neck cancer.
Data Sources: MEDLINE® search of the literature from 1966-2001.
Data Synthesis: Four types of agents (i.e., antimicrobial, coating, anti-inflammatory, and cytokine-like agents) have been evaluated for the management of RT-induced oral mucositis in patients with head and neck cancer. Most of the published studies had relatively small sample sizes and used inconsistent measures to evaluate the extent and severity of oral mucositis. Therefore, definitive conclusions regarding the effectiveness of any of the agents tested in the prevention and treatment of RT-induced oral mucositis cannot be drawn.
Conclusions: Oral mucositis remains the most common complication among patients with head and neck cancer. Although a number of strategies and products are being investigated and new directions are promising, the therapies tested to date have not produced consistent results.
Implications for Nursing: The most effective measure to treat RT-induced mucositis in patients with head and neck cancer is frequent oral rinsing with a bland mouthwash, such as saline or a sodium bicarbonate rinse, to reduce the amount of oral microbial flora. Dental care, consistent oral assessments, and the initiation of a standardized oral hygiene protocol before the initiation of cancer treatment are the most effective approaches for oral mucositis.
Jump to a section
References
Adamietz, I.A., Rahn, R., Bottcher, H.D., Schafer, V., Reimer, K., & Fleischer, W. (1998). Prophylaxis with povidoneiodine against induction of oral mucositis by radiochemotherapy. Supportive Care in Cancer, 6, 373-377.
Bapsy, P.P., Doval, D.C., Kannan, V., & Anantha, N. (1995). Hematopoietic growth factors in radiation mucositis. Journal of the Association of Physicians of India, 3(Suppl.), 11-13.
Barker, G., Loftus, L., Cuddy, P., & Barker, B. (1991). The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis. Oral Surgery, Oral Medicine, and Oral Pathology, 71, 288-293.
Beck, S. (1979). Impact of a systematic oral care protocol on stomatitis after chemotherapy. Cancer Nursing, 2, 185-199.
Biron, P., Sebban, C., Gourmet, R., Chvetzoff, G., Philip, I., & Blay, J.Y. (2000). Research controversies in management of oral mucositis. Supportive Care in Cancer, 8, 68-71.
Carl, W., & Emrich, L.S. (1991). Management of oral mucositis during local radiation and systemic chemotherapy: A study of 98 patients. Journal of Prosthetic Dentistry, 66, 361-369.
Carter, D.L., Hebert, M.E., Smmk, K., Leopold, K.A., Clough, R.L., & Brizel, D.M. (1999). Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers. Head and Neck, 21, 760-766.
Cengiz, M., Ozyar, E., Oztürk, D., Akyol, F., Atahan, I.L., & Hayran, M. (1999). Sucralfate in the prevention of radiation-induced oral mucositis. Journal of Clinical Gastroenterology, 28(1), 40-43.
Dodd, M.J., Larson, P.J., Dibble, S.L., Miaskowski, C., Greenspan, D., MacPhail, L., et al. (1996). Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncology Nursing Forum, 23, 921-927.
Dudjak, L.A. (1987). Mouth care for mucositis due to radiation therapy. Cancer Nursing, 10, 131-140.
Epstein, J.B. (1990). Infection prevention in bone marrow transplantation and radiation patients. National Cancer Institute Monographs, 9, 73-85.
Epstein, J.B., & Stevenson-Moore, P. (1986). Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy. Oral Surgery, Oral Medicine, and Oral Pathology, 62, 145-148.
Epstein, J.B., Stevenson-Moore, P., Jackson, S., Mohamed, J.H., & Spinelli, J.J. (1989). Prevention of oral mucositis in radiation therapy: A controlled study with benzydamine hydrochloride rinse. International Journal of Radiation Oncology, Biology, Physics, 16, 1571-1575.
Epstein, J.B., & Wong, F.L. (1994). The efficacy of sulcrafate suspension in the prevention of oral mucositis due to radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 28, 693-698.
Ferretti, G.A., Brown, A.T., Raybould, T.P., & Lillich, T.T. (1990). Oral antimicrobial agents-Chlorhexidine. National Cancer Institute Monographs, 9, 51-55.
Ferretti, G.A., Raybould, T.P., Brown, A.T., Macdonald, J.S., Greenwood, M., Maruyama, Y., et al. (1990). Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: A randomized double-blind trial. Oral Surgery, Oral Medicine, and Oral Pathology, 69, 331-338.
Foote, R., Loprinzi, C.L., Frank, A.R., O'Fallon, J.R., Gulavita, S., Tewfik, H.H., et al. (1994). Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. Journal of Clinical Oncology, 12, 2630-2633.
Franzen, L., Henriksson, R., Littbrand, B., & Zackrisson, B. (1995). Effects of sulcrafate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study. Acta Oncologica, 34, 219-223.
Graham, K.M., Pecoraro, D.A., Ventura, M., & Meyer, C.C. (1993). Reducing the incidence of stomatitis using a quality assessment and improvement approach. Cancer Nursing, 16, 117-122.
Hanson, W.R., Marks, J.E., Reddy, S.P., Simon, S., & Mihalp, W.E. (1997). Protection from radiation-induced oral mucositis by a mouth rinse containing the prostaglandin E1 analog, misoprostol: A placebo controlled double blind clinical trial. Advances in Experimental Medicine and Biology,400B, 811-818.
Henriksson, R., Franzen, L., Edbom, C., & Littbrand, B. (1995). Sucralfate: Prophylaxis of mucosal damage during cancer therapy. Scandinavian Journal of Gastroenterology, Supplement, 210, 45-47.
Kannan, V., Bapsy, P.P., Anantha, N., Doval, D.C., Vaithianathan, H., Banumathy, G., et al. (1997). Efficacy and safety of granulocyte macroph-age-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. International Journal of Radiation Oncology, Biology, Physics, 37, 1005-1010.
Kim, J.H., Chu, F., Lakshmi, V., & Houde, R. (1985). A clinical study of benzydamine for the treatment of radiotherapy-induced mucositis of the oropharynx. International Journal of Tissue Reactions, 7, 215-218.
Leborgne, J.H., Leborgne, F., Zubizarreta, E., Ortega, B., & Mezzera, J. (1998). Corticosteroids and radiation mucositis in head and neck cancer: A double-blind placebo-controlled randomized trial. Radiotherapy and Oncology, 47, 145-148.
Lievens, Y., Haustermans, K., Van den Weyngaert, D., Van den Bogaert, W., Scalliet, P., Hutsebaut, L., et al. (1998). Does sucralfate reduce the acute side effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiotherapy and Oncology, 47, 149-153.
Madeya, M.L. (1996). Oral complications from cancer therapy: Part II- Nursing implications for assessment and treatment. Oncology Nursing Forum, 23, 808-819.
Makkonen, T.A., Bostrom, P., Vilja, P., & Joensuu, H. (1994). Sucralfate mouth washing in the prevention of radiation-induced mucositis: A placebo-controlled double-blind randomized study. International Journal of Radiation Oncology, Biology, Physics, 30, 177-182.
Makkonen, T.A., Minn, H., Jekunen, A., Vilja, P., Tuominen, J., & Joensuu, H. (2000). Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: A prospective randomized study. International Journal of Radiation Oncology, Biology, Physics, 46, 525-534.
Meredith, R., Salter, M., Kim, R., Spencer, S., Weppelmann, B., Rodu, B., et al. (1997). Sucralfate for radiation mucositis: Results of a double-blind randomized trial. International Journal of Radiation Oncology, Biology, Physics, 37, 275-279.
Miaskowski, C. (1990). Oral complications of cancer therapies. Management of mucositis during therapy. National Cancer Institute Monographs, 9, 95-98.
Mose, S., Adamietz, I.A., Saran, F., Thilmann, C., Heyd, R., Knecht, R., et al. (1997). Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis? American Journal of Clinical Oncology, 20, 407-411.
Mueller, B.A., Millheim, E.T., Farrington, E.A., Brusko, C., & Wiser, T.H. (1995). Mucositis management practices for hospitalized patients: National survey results. Journal of Pain and Symptom Management, 10, 510-520.
National Cancer Institute. (2000). Oral complications of chemotherapy and head/neck radiation, supportive care-health professionals. Retrieved February 15, 2001, from http://cancernet.nci.nih.gov/pdq/pdq_supportive_care.shtml
National Institutes of Health Consensus Development Panel. (1990). Consensus statement: Oral complications of cancer therapies: Diagnosis, prevention, and treatment. National Cancer Institute Monographs, 9, 3-8.
Nicolatou, O., Sotiropoulou-Lontou, A., Skarlatos, J., Kyprianou, K., Kolitsi, G., & Dardoufas, K. (1998). A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during x-radiation therapy: A preliminary report. International Journal of Radiation Oncology, Biology, Physics, 42, 551-556.
Oguchi, M., Shikama, N., Sasaki, S., Gomi, K., Katsuyama, Y., Ohta, S., et al. (1998). Mucosa-adhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis. International Journal of Radiation Oncology, Biology, Physics, 40, 1033-1037.
Okuno, S.H., Foote, R.L., Loprinzi, C.L., Gulavita, S., Sloan, J.A., Earle, J., et al. (1997). A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer, 79, 2193-2199.
Prada, A., & Chiesa, F. (1987). Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. International Journal of Tissue Reactions, 9, 115-119.
Prada, A., Lozza, L., Moglia, D., Sala, L., & Chiesa, F. (1985). Effects of benzydamine on radio-polychemotherapeutic mucositis of the oral cavity. International Journal of Tissue Reactions, 7, 237-239.
Raber-Durlacher, J.E. (1999). Current practices for management of oral mucositis in cancer patients. Supportive Care in Cancer, 7, 71-74.
Rahn, R., Adamietz, I.A., Boettcher, H.D., Schaefer, V., Reimer, K., & Fleischer, W. (1997). Povidone-iodine to prevent mucositis in patients with antineoplastic radiochemotherapy. Dermatology, 195(Suppl. 2), 57-61.
Rosso, M., Blasi, G., Gherlone, E., & Rosso, R. (1997). Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy. Journal of Chemotherapy, 9, 382-385.
Rothwell, B.R., & Spektor, W.S. (1990). Palliation of radiation-related mucositis. Special Care in Dentistry, 10(1), 21-25.
Rovirosa, A., Ferre, J., & Biete, A. (1998). Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 41, 747-754.
Samaranayake, L.P., Robertson, A.G., MacFarlane, T.W., Hunter, I.P., MacFarlane, G., Soutar, D.S., et al. (1988). The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clinical Radiology, 39, 291-294.
Scully, C., & Epstein, J.B. (1996). Oral health for the cancer patient. European Journal of Cancer, Part B: Oral Oncology,32B, 281-292.
Sonis, S.T. (1998). Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncology, 34(1), 39-43.
Spijkervet, F.K., van Saene, H.K., Panders, A.K., Vermey, A., van Saene, J.J., Mehta, D.M., et al. (1989). Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis. Oral Surgery, Oral Medicine, and Oral Pathology, 67, 154-161.
Spijkervet, F.K., van Saene, H.K., van Saene, J.J., Panders, A.K., Mehta, D.M., & Fidler, V. (1991). Effect of selective elimination of the oral flora in irradiated head and neck cancer patients. Journal of Surgical Oncology, 46, 167-173.
Spijkervet, F.K., van Saene, H.K., van Saene, J.J., Panders, A.K., Vermey, A., & Mehta, D.M. (1990). Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients. Journal of Oral Pathology and Medicine, 19, 486-489.
Symonds, R.P. (1998). Treatment-induced mucositis: An old problem with new remedies. British Journal of Cancer, 77, 1689-1695.
Symonds, R.P., Mcllroy, P., Khorrami, J., Paul, J., Pyper, E., Alcock, S.R., et al. (1996). The reduction of radiation mucositis by selective decontamination antibiotic pastilles: A placebo-controlled double-blind trial. British Journal of Cancer, 74, 312-317.
Verdi, C.J. (1993). Cancer therapy and oral mucositis: An appraisal of drug prophylaxis. Drug Safety, 9, 185-195.